论文部分内容阅读
目的评价加替沙星序贯治疗下呼吸道感染的疗效和成本/效果比。方法将60例下呼吸道感染的患者随机分为加替沙星序贯治疗组(30例)和输液治疗组(30例),观察两组的临床疗效,同时对两种疗法采用药物经济学的最小成本法进行分析。结果加替沙星序贯治疗组和输液治疗组在治疗成本上有显著差异。结论加替沙星序贯疗法治疗下呼吸道感染经济合理,安全有效,值得临床推广。
Objective To evaluate the efficacy and cost / benefit ratio of sequential treatment of Gatifloxacin for lower respiratory tract infection. Methods Sixty patients with lower respiratory tract infection were randomly divided into gatifloxacin sequential treatment group (30 cases) and infusion treatment group (30 cases). The clinical efficacy of the two groups were observed. Meanwhile, Analysis of the minimum cost method. Results Gatifloxacin sequential therapy group and infusion therapy group in the treatment costs were significantly different. Conclusion Gatifloxacin sequential therapy for lower respiratory tract infection is reasonable, safe and effective, and worthy of clinical promotion.